BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 3464612)

  • 1. Regulated expression of the c-myb and c-myc oncogenes during erythroid differentiation.
    Kirsch IR; Bertness V; Silver J; Hollis GF
    J Cell Biochem; 1986; 32(1):11-21. PubMed ID: 3464612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protooncogene expression in normal, preleukemic, and leukemic murine erythroid cells and its relationship to differentiation and proliferation.
    Robert-Lézénès J; Meneceur P; Ray D; Moreau-Gachelin F
    Cancer Res; 1988 Jul; 48(14):3972-6. PubMed ID: 3164254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric oxide-releasing agents and cGMP analogues inhibit murine erythroleukemia cell differentiation and suppress erythroid-specific gene expression: correlation with decreased DNA binding of NF-E2 and altered c-myb mRNA expression.
    Suhasini M; Boss GR; Pascual FE; Pilz RB
    Cell Growth Differ; 1995 Dec; 6(12):1559-66. PubMed ID: 9019161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of differentiation in Friend-erythroleukemia cells by aclacinomycin A: early transient decrease in c-myc and c-myb mRNA levels.
    Schaefer A; Dressel A; Lingelbach K; Schmidt CA; Steinheider G; Marquardt H
    Leukemia; 1992 Aug; 6(8):828-33. PubMed ID: 1640736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constitutive c-myc oncogene expression blocks mouse erythroleukaemia cell differentiation but not commitment.
    Coppola JA; Cole MD
    Nature; 1986 Apr 24-30; 320(6064):760-3. PubMed ID: 3458027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in gene expression during hexamethylene bisacetamide induced erythroleukemia differentiation.
    Marks PA; Ramsay R; Sheffery M; Rifkind RA
    Prog Clin Biol Res; 1987; 251():253-68. PubMed ID: 3481077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of a transfected human c-myc oncogene inhibits differentiation of a mouse erythroleukaemia cell line.
    Dmitrovsky E; Kuehl WM; Hollis GF; Kirsch IR; Bender TP; Segal S
    Nature; 1986 Aug 21-27; 322(6081):748-50. PubMed ID: 3528861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induced erythroleukemia differentiation: cellular and molecular aspects.
    Rifkind RA; Sheffery M; Marks PA
    Blood Cells; 1987; 13(1-2):277-84. PubMed ID: 3311222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular and cellular mechanisms of leukemic hemopoietic cell differentiation: an analysis of the Friend system.
    Tsiftsoglou AS; Wong W
    Anticancer Res; 1985; 5(1):81-99. PubMed ID: 3888045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deregulated expression of c-myc by murine erythroleukaemia cells prevents differentiation.
    Prochownik EV; Kukowska J
    Nature; 1986 Aug 28-Sep 3; 322(6082):848-50. PubMed ID: 3528863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of protooncogenes c-myb and c-myc during the hexamethylene bisacetamide (HMBA)-induced commitment to terminal differentiation of murine erythroleukemia cells].
    Chen ZX
    Zhonghua Zhong Liu Za Zhi; 1991 Jul; 13(4):261-4. PubMed ID: 1806345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. cAMP-induced NF-kappaB (p50/relB) binding to a c-myb intronic enhancer correlates with c-myb up-regulation and inhibition of erythroleukemia cell differentiation.
    Suhasini M; Reddy CD; Reddy EP; DiDonato JA; Pilz RB
    Oncogene; 1997 Oct; 15(15):1859-70. PubMed ID: 9362453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of ornithine decarboxylase inhibition on c-myc expression during murine erythroleukemia cell proliferation and differentiation.
    Watanabe T; Sherman M; Shafman T; Iwata T; Kufe D
    J Cell Physiol; 1986 Jun; 127(3):480-4. PubMed ID: 3458709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythroid differentiation and modulation of c-myc expression induced by antineoplastic drugs in the human leukemic cell line K562.
    Tonini GP; Radzioch D; Gronberg A; Clayton M; Blasi E; Benetton G; Varesio L
    Cancer Res; 1987 Sep; 47(17):4544-7. PubMed ID: 3476195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The level of c-myc transcript in differentiation-defective mouse erythroleukemia cells.
    Sasaki H; Watanabe T; Nomura S; Oishi M
    Jpn J Cancer Res; 1987 Aug; 78(8):776-9. PubMed ID: 3115922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Myb dependent pathway maintains Friend murine erythroleukemia cells in an immature and proliferating state.
    Chen J; Kremer CS; Bender TP
    Oncogene; 2002 Mar; 21(12):1859-69. PubMed ID: 11896618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. c-myb effects on kinetic events during MEL cell differentiation.
    Danish R; el-Awar O; Weber BL; Langmore J; Turka LA; Ryan JJ; Clarke MF
    Oncogene; 1992 May; 7(5):901-7. PubMed ID: 1533276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel system to identify Myb target promoters in friend murine erythroleukemia cells.
    Chen J; Bender TP
    Blood Cells Mol Dis; 2001; 27(2):429-36. PubMed ID: 11500057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The induction of Friend erythroleukaemia differentiation is markedly affected by expression of a transfected c-myb cDNA.
    McMahon J; Howe KM; Watson RJ
    Oncogene; 1988 Dec; 3(6):717-20. PubMed ID: 2577875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. c-myc and c-myb oncoproteins during induced maturation of myeloid and erythroid human leukemic cell lines.
    Pedrazzoli P; Bains MA; Watson R; Fisher J; Hoy TG; Jacobs A
    Cancer Res; 1989 Dec; 49(24 Pt 1):6911-6. PubMed ID: 2684403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.